Details of the Drug Reposition

General Information of This Drug (ID: DMR0N74)

Drug Name	LAM-002 DMR0N74

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Chronic lymphocytic leukaemia	DISEXWC3	2A82.0	Phase 2	[1]
Non-hodgkin lymphoma	DISS2Y8A	2B33.5	Phase 2	[1]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT02594384) A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's Lymphoma (LAM-002A/NHL) (LAM-002A/NHL). U.S. National Institutes of Health.